Irvine Scientific says it will build a media R&D lab at its Orange County site

By Staff Reporter

- Last updated on GMT

iStock/JVisentin
iStock/JVisentin

Related tags: Dna, Cell culture

Irvine Scientific has announced plans for an R&D centre at its site in Irvine, California citing increasing biopharma industry demand for cell culture and media regents.  

In addition to the R&D centre, the new building will house departments currently located at its headquarters in neighbouring Santa Ana. Irvine said the reorganisation will enable it to “expand other capabilities, such as media customization​.”

COO Tim Mullane said the new space will allow “us to expand our space and staff dedicated to advancing cell culture technology important​.”

The expansion plan follows a number of product launches.

In July​ last year, Irvine launched a medium for neuronal cells for pharmaceutical firms developing regenerative medicines and drugs for central nervous system disorders.

A month later it released BalanCD HEK293, a system designed to increase viral vector and recombinant protein production yields.

The technology comprises a chemically defined media that supports the growth of human embryonic kidney (HEK293) cells, which can be used for the production of proteins and gene therapy vectors.

It is designed to be used to support growth of the cell lines before and after transfection – in other systems media but be changed after genetic material has been inserted.

In January​, Irvine rolled out a chemically-defined, animal component-free medium for T cell culture.

Last month​, Irvine launched a serum-free, xeno-free basal medium designed for the expansion of hematopoietic progenitors for customers working with HSPCs.

Related news

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

How Viral Safety Testing Will Evolve

How Viral Safety Testing Will Evolve

Viral Safety for mAb: Prevent, Detect, Remove | 20-May-2020 | Event Programme

The pressure to shorten delivery times and reduce costs for biologics are driving an evolution in the biomanufacturing space. Many of the methods used...

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Related suppliers

Follow us

Products

View more

Webinars